Jul 27, 2021 8:00 am EDT Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors
Jun 17, 2021 9:00 am EDT Capricor Therapeutics to Present Findings from HOPE-2 Open-Label Extension Study at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference
May 18, 2021 8:30 am EDT Capricor To Present Preclinical Data for Exosome-mRNA Vaccine for SARS-CoV-2 at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
May 13, 2021 4:05 pm EDT Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 12, 2021 9:00 am EDT Capricor to Present at the American Society of Gene and Cell Therapy’s 24th Annual Meeting
May 06, 2021 8:30 am EDT Capricor Therapeutics to Present First Quarter 2021 Financial Results and Recent Corporate Update on May 13
Apr 29, 2021 8:00 am EDT Capricor Therapeutics Signs Exclusive Worldwide License Agreement with Johns Hopkins University to Expand its Exosome Platform Technology Portfolio
Mar 11, 2021 4:01 pm EST Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Mar 09, 2021 9:15 am EST Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform